A Study of JNJ-54767414 (HuMax CD38) (Anti-CD38 Monoclonal Antibody) in Combination With Backbone Treatments for the Treatment of Patients With Multiple Myeloma

Name: A Study of JNJ-54767414 (HuMax CD38) (Anti-CD38 Monoclonal Antibody) in Combination With Backbone Treatments for the Treatment of Patients With Multiple Myeloma
Published: 2014
License: Public Domain

Janssen Research & Development, LLC · 2014

ClinicalTrials.gov · Datasets · License: Public Domain · 2014

Open Source ↗

multiple-myeloma

multiple myeloma, daratumumab, jnj-54767414, velcade-dexamethasone, velcade-melphalan-prednisone, velcade-thalidomide-dexamethasone, pomalidomide-dexamethasone, carfilzomib-dexamethasone, carfilzomib-lenalidomide-dexamethasone, anti-cd38 monoclonal antibody, immunomodulatory drug, imid

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Study of JNJ-54767414 (HuMax CD38) (Anti-CD38 Monoclonal Antibody) in Combination With Backbone Treatments for the Treatment of Patients With Multiple Myeloma

Related documents